Company news
Azenta, Inc. (NASDAQ:AZTA) news
Azenta, Inc. news releases on 6ix. Latest, Sep 4, 2026: Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
Press releases & updates
Azenta Receives Full Repayment of $35 Million Vendor Loan Related to Sale of B Medical Systems
September 4, 2026
AZENTA ANNOUNCES LEADERSHIP TRANSITION
August 24, 2026
Azenta Reports Third Quarter Results for Fiscal 2026, Ended June 30, 2026.
August 4, 2026
Azenta Announces Fiscal 2026 Third Quarter Conference Call and Webcast
July 22, 2026
Azenta Completes Sale of B Medical Systems
July 8, 2026
Azenta Publishes 2025 Environmental, Social, and Governance (ESG) Report
May 21, 2026
Azenta Reports Second Quarter Results for Fiscal 2026, Ended March 31, 2026, Updates Full Year Fiscal 2026 Guidance, and Extends Long-Range Plan to 2029
May 5, 2026
Azenta Announces Fiscal 2026 Second Quarter Conference Call and Webcast
April 29, 2026
Azenta Life Sciences Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
April 6, 2026
Azenta Completes Strategic Acquisition of UK Biocentre Limited, to Expand Biorepository Capabilities
March 4, 2026
Azenta to Participate in Raymond James 47th Annual Institutional Investor Conference
February 24, 2026
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
February 9, 2026
Azenta Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
February 4, 2026
Azenta Announces Fiscal 2026 First Quarter Conference Call and Webcast
January 21, 2026
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.A R.L.
December 30, 2025
Azenta Enters Definitive Agreement for the Sale of its B Medical Systems Business to THELEMA S.À R.L.
December 28, 2025
Azenta Authorizes $250 Million Share Repurchase Program
December 9, 2025
Azenta Reports Fourth Quarter and Full Year Fiscal 2025 Results, Ended September 30, 2025
November 20, 2025
Azenta Announces Fiscal 2025 Fourth Quarter and Full Year Conference Call and Webcast
November 11, 2025
Azenta Life Sciences Partners with PRECEDE Foundation to Advance Early Detection of Pancreatic Cancer
November 3, 2025
Azenta to Host Investor Day at its Biorepository Facility in Indianapolis, Indiana
October 14, 2025
Azenta Reports Third Quarter Results for Fiscal 2025, Ended June 30, 2025; Reiterates Full Year Fiscal 2025 Guidance
August 4, 2025
Azenta Life Sciences Partners with Frenova, a Division of Fresenius Medical Care, and Nephronomics to Advance Genomic Research in Nephrology
July 30, 2025
Azenta to Participate in 10th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
July 29, 2025
Azenta Announces Fiscal 2025 Third Quarter Earnings Conference Call and Webcast
July 22, 2025
Azenta Life Sciences and Form Bio Announce Strategic Partnership to Advance AAV Gene Therapy Development
May 12, 2025
Azenta Reports Second Quarter Results for Fiscal 2025, Ended March 31, 2025
May 6, 2025
Azenta Announces Fiscal 2025 Second Quarter Earnings Conference Call and Webcast
April 23, 2025
Azenta Publishes its 2024 Environmental, Social, & Governance (ESG) Report
March 23, 2025
Azenta to Participate in the Virtual KeyBanc Capital Markets Healthcare Forum
March 9, 2025
Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024
February 4, 2025
Azenta Announces the Election of Dipal Doshi to its Board of Directors
January 29, 2025
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast
January 26, 2025
UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence
January 22, 2025
Azenta to Participate in Stephens Annual Investment Conference
November 13, 2024
Azenta Reports Fourth Quarter and Full Year Fiscal 2024 Results; Announces the Plan to Sell B Medical Systems and Appoints Lawrence Y. Lin as CFO
November 11, 2024
Azenta Announces Fiscal 2024 Fourth Quarter and Full Year Earnings Conference Call and Webcast
November 3, 2024
Azenta Announces the Addition of Three New Independent Directors Effective Immediately and New Initiative to Drive Value
November 3, 2024
Azenta Obtains Regulatory Approval for Clinical Long-Read Whole Genome Sequencing Test
October 29, 2024
AZENTA ANNOUNCES APPOINTMENT OF JOHN P. MAROTTA AS CEO
September 3, 2024
GENEWIZ from Azenta Life Sciences Celebrates 25 Years of Advancing Scientific Discoveries at GENEWIZ Week Event
August 11, 2024
Azenta Reports Third Quarter Results for Fiscal 2024, Ended June 30, 2024
August 5, 2024
Azenta to Participate in 9th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference
August 4, 2024
Azenta Announces Fiscal 2024 Third Quarter Earnings Conference Call and Webcast
July 23, 2024
FinnGen Selects Azenta to Propel Personalized Medicine for Population Health Study
July 21, 2024
Azenta Announces Collaboration with the Crohn's & Colitis Foundation to Support its Crohn's Disease and Ulcerative Colitis Clinical Research
June 3, 2024
Azenta to Participate in the Jefferies Global Healthcare Conference
May 22, 2024
Azenta Opens the Doors to Its New Genomics Laboratory in Oxford, UK
May 12, 2024
Azenta Reports Second Quarter Results for Fiscal 2024, Ended March 31, 2024
May 7, 2024
Azenta Announces CEO Succession Plan
May 7, 2024